Cologne — AYOXXA Biosystems GmbH, an international biotechnology company, announced that Dr. Gerald Möller has joined the company’s supervisory board as an independent board director and chairman of the board. With 40 years of experience in Pharma, Diagnostics and Biotech, Dr. Möller will guide AYOXXA’s strategic expansion from life science research into disease specific applications, […]
NEW YORK — At a meeting with analysts and investors today, members of the senior management team of NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, plan to unveil the company’s strategic roadmap to drive continued growth and expand the market for its nCounter® Analysis System […]
SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the commercial launch of the nCounter® RNA:Protein PanCancer Immune Profiling Panel. The panel can be analyzed on the full line of nCounter Analysis Systems, including the new nCounter SPRINT™ Profiler, utilizing breakthrough technology, which […]
SAN CLEMENTE, CA — Micro Imaging Technology, Inc. (otcqb:MMTC) announced that its MIT 1000 System can now identify Enterococcus faecalis, a bacterial species found in human feces and in the intestines of many warm-blooded animals; occasionally found in urinary infections and in blood and heart lesions in cases of subacute endocarditis. E. faecalis can cause […]
Watertown, Massachusetts — PathoGenetix announces commercial launch and shipment of the Resolution Microbial Genotyping System for rapid bacterial serotyping and strain typing. Production of commercial instruments for sales and delivery was a key milestone for the Genome Sequence Scanning Technology. The RESOLUTION Microbial Genotyping System is fully automated and includes the instrument, pathogen databases, bioinformatics […]
SAN DIEGO, Calif. — Agena Bioscience today announced the establishment of a subsidiary in Shanghai, a commercial and financial hub from which many biotech and life science firms serve the growing number of genomic testing laboratories in mainland China. “The Chinese market represents a significant portion of Agena Bioscience’s global sales with almost sixty MassARRAY® […]
Pleasanton, California –– IntegenX Inc., the global market leader for Rapid Human DNA identification, is pleased to announce the introduction of the RapidHIT ID System, providing forensic DNA profiles with unprecedented speed and ease of use. Whether deployed in a forensic lab or in other settings such as a law enforcement booking environment, in 90 […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced commercial availability of a new high throughput single-cell mRNA sequencing workflow for its C1TM system to enable large-scale studies to characterize heterogeneous samples. This validated workflow includes a new advanced integrated fluidic circuit (IFC) and reagent kit that significantly increases throughput and ease-of-use, while simultaneously […]
FRANKLIN LAKES, N.J. — BD Life Sciences, a segment of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE: BDX), today announced it has completed the acquisition of Cellular Research, Inc. BD is a global leader in characterizing and isolating single cells for analysis, with more than 30 years of experience in developing […]
Pleasanton, California – The revolutionary RapidHIT® System from IntegenX delivered a stunning arrest in the UK last week. A suspect was arrested for a minor crime and swabbed for a DNA reference sample while in custody. His DNA profile was generated in less than two hours using the RapidHIT System at UK forensic laboratory, Key […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
